Aqr Capital Management LLC Pfizer Inc Transaction History

Aqr Capital Management LLC

$58.2 Billion
Q1 2024

A detailed history of Aqr Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 602,994 shares of PFE stock, worth $16.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

602,994

Previous 1,739,820 65.34%

Holding current value

$16.9 Million

Previous $50.1 Million 66.59%

% of portfolio

0.03%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $29.4 Million - $33.8 Million	-1,136,826 Reduced 65.34%	602,994 $16.7 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $88.9 Million - $116 Million	-3,403,378 Reduced 66.17%	1,739,820 $50.1 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $8.42 Million - $9.85 Million	-262,490 Reduced 4.86%	5,143,198 $171 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $144 Million - $166 Million	-3,977,138 Reduced 42.39%	5,405,688 $198 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $18 Million - $23.4 Million	-456,997 Reduced 4.64%	9,382,826 $383 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $35.3 Million - $46.1 Million	-845,459 Reduced 7.91%	9,839,823 $504 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $5.27 Million - $6.44 Million	120,527 Added 1.14%	10,685,282 $468 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $6.46 Million - $7.65 Million	-138,739 Reduced 1.3%	10,564,755 $554 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $176 Million - $219 Million	3,857,765 Added 56.35%	10,703,494 $554 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $49.2 Million - $72.9 Million	1,190,989 Added 21.06%	6,845,729 $404 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $9.89 Million - $12.7 Million	252,045 Added 4.67%	5,654,740 $243 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $2.82 Million - $3.2 Million	78,542 Added 1.48%	5,402,695 $210 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $34.5 Million - $38.9 Million	1,030,309 Added 24.0%	5,324,153 $192 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $121 Million - $154 Million	-3,610,202 Reduced 45.68%	4,293,844 $156 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $64.8 Million - $76 Million	-2,040,038 Reduced 20.52%	7,904,046 $290 Million
Q2 2020 Aug 17, 2020	SELL	$30.12 - $36.54 $33.8 Million - $41 Million	-1,121,336 Reduced 10.13%	9,944,084 $325 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $60.1 Million - $85.9 Million	-2,223,237 Reduced 16.73%	11,065,420 $361 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $10.4 Million - $11.8 Million	316,807 Added 2.44%	13,288,657 $517 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $206 Million - $267 Million	-6,327,978 Reduced 32.79%	12,971,850 $466 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $205 Million - $230 Million	-5,543,071 Reduced 22.31%	19,299,828 $836 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $90 Million - $98.9 Million	-2,401,115 Reduced 8.81%	24,842,899 $1.05 Billion
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $157 Million - $179 Million	4,092,255 Added 17.68%	27,244,014 $1.19 Billion
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $300 Million - $364 Million	8,701,301 Added 60.21%	23,151,759 $1.02 Billion
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $51.8 Million - $55.2 Million	-1,571,213 Reduced 9.81%	14,450,458 $526 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $97.9 Million - $114 Million	-3,068,295 Reduced 16.07%	16,021,671 $569 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $58.8 Million - $62.4 Million	-1,769,104 Reduced 8.48%	19,089,966 $691 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $647 Million - $712 Million	20,859,070	20,859,070 $745 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Pfizer Inc Transaction History